• Latest Posts
In Depth 9 Nov 2023

Blood tests for Alzheimer’s: a hit or a miss?

In Depth 26 Oct 2023

Behind closed doors: The unseen controversies and scandals in Alzheimer’s drug trials

Partnership to progress neurodegenerative disorder treatments

Minoryx can start phase 3 trial for cerebral adrenoleukodystrophy patients

Biogen ALS drug gets FDA ok

In Depth 21 Apr 2023

Gut microbiome: a promising target for Parkinson’s

€260M fund addresses dementia investment shortfall